Pfizer has announced its plans to proceed with the development of a once-daily version of its weight loss pill, danuglipron, following positive results from an ongoing early-stage study. The company has evaluated various formulations of the drug and has identified one that exhibits the most favorable safety profile and efficacy in terms of how the
0 Comments
Cryptocurrency exchange-traded funds are gaining traction on Wall Street, with a new wave of ethereum ETFs on the horizon. This development comes as Spot ether ETFs are set to enter the market pending approval from the U.S. Securities and Exchange Commission. Matthew Hougan, the chief investment officer of Bitwise Asset Management, is optimistic about the
0 Comments
With NASA astronauts currently docked at the International Space Station for a longer duration than expected, the agency’s leadership is now considering potential alternatives to using Boeing’s Starliner for the crew’s return to Earth. Even though Boeing’s spacecraft remains the primary option for the return of the crew, officials are open to exploring other possibilities
0 Comments